Apellis Pharmaceuticals, Inc. (APLS)

Intercept Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-228.17	-197.88	-528.63	-652.17	-746.35	-344.87
Depreciation & Amortization	1.8	1.8	1.78	1.55	1.49	0.86
Other Amortization	2.45	1.56	0.3	0.46	0.96	15.54
Loss (Gain) From Sale of Assets	-	-	0.12	-	-	-
Stock-Based Compensation	108.36	114.13	105.95	91.09	70.67	45.38
Other Operating Activities	-	10.89	26	61.09	203.63	103.03
Change in Accounts Receivable	90.3	-58.48	-198.72	2.38	-10.1	-
Change in Inventory	6.67	-10.76	-60.65	-69.4	-16.32	-
Change in Accounts Payable	16	1.09	0.17	18.69	10.49	-0.05
Change in Other Net Operating Assets	9	49.79	58.94	32.57	-77.59	19.64
Operating Cash Flow	4.49	-87.87	-594.74	-513.75	-563.13	-160.49
Capital Expenditures	-0.08	-0.4	-0.77	-1.52	-1.1	-5.42
Sale of Property, Plant & Equipment	-	-	0.1	-	-	-
Investment in Securities	-	-	-	61.42	248.72	-311.57
Investing Cash Flow	-0.08	-0.4	-0.67	59.89	247.62	-316.99
Long-Term Debt Issued	-	365.45	-	-	-	322.87
Net Debt Issued (Repaid)	-	365.45	-	-	-	322.87
Issuance of Common Stock	11.04	18.83	461.04	405.84	398.02	392.42
Repurchase of Common Stock	-0.04	-0.06	-11.04	-5.68	-1.79	-
Other Financing Activities	-5.63	-234.98	-55.5	-34.5	-4	-23.11
Financing Cash Flow	5.37	149.24	394.5	365.66	392.24	692.18
Foreign Exchange Rate Adjustments	0.25	-0.66	0.14	-0.49	-2.02	0.36
Net Cash Flow	10.04	60.31	-200.78	-88.68	74.71	215.06
Free Cash Flow	4.41	-88.27	-595.51	-515.27	-564.23	-165.91
Free Cash Flow Margin	0.58%	-11.30%	-150.16%	-683.18%	-847.66%	-66.19%
Free Cash Flow Per Share	0.04	-0.71	-5.02	-4.86	-6.68	-2.21
Cash Interest Paid	33.51	29.37	3.29	5	10.27	12.93
Cash Income Tax Paid	2.58	1.65	-1.76	4.92	0.05	1.65
Levered Free Cash Flow	106.22	-35.7	-404.84	-304.6	-351.61	-52.88
Unlevered Free Cash Flow	132.68	-12.01	-386.65	-284.66	-344.3	-49.7
Change in Net Working Capital	-141.39	24.42	170.41	4.14	80.19	-43.06

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q